| |
|
|
|
Antares Pharma Inc.  
|
|
3.36 -0.01 (-0%) |
09-21 10:03 |
|
Open: |
3.37 |
Pre close: |
3.37 |
Target:
|
4.10
|
|
High: |
3.405 |
Low: |
3.355 |
Resistance:
|
3.51
3.77
|
|
Volume: |
296,738 |
Market Cap: |
529M |
Support:
|
3.08
2.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.31
 |
MACD |
MACD(12,26):
|
0.03 |
|
MA(20): |
3.40  |
Signal(12,26,9): |
0.05 |
|
MA(100): |
2.87 |
Stochastic Oscillator |
%K(14,3):
|
53.38 |
|
MA(250): |
2.50 |
%D(3): |
45.31 |
|
Average Volume(K) |
3-Month: |
111495
|
52-Week |
High:
|
4.09 |
|
10-Days: |
97502 |
Low: |
1.58 |
|
RSI |
RSI(14):
|
54.68 |
Change(%): |
12.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.120 |
Return on Equity (ttm) |
-60.4 |
Shares Out. (M) |
157.44 |
|
EPS Est. Current Year |
-0.100 |
Return on Assets (ttm) |
-25.0 |
Shares Float (M) |
141.27 |
|
EPS Est. Next Year |
0.010 |
PEG Ratio |
-0.41 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
5.6 |
% Held by Institutions |
25.80 |
|
Forward EPS |
0.050 |
Gross Profit (p.s.) |
0.041 |
Shares Short (K) |
6326 |
|
Book Value (p.s.) |
20.250 |
EBITDA (p.s.) |
-0.027 |
P/E |
-28.13 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.17 |
|
Profit Margin |
-36.98 |
Operating Cash Flow
(M) |
-23.08 |
P/S |
1476000000.00 |
|
Operating Margin |
-33.05 |
Levered Free Cash Flow
(M) |
-9.28 |
P/CF |
-23.02 |
|
|
|
|
|
|
